The natural history and epidemiology of herpes simplex viruses

Herpes Simplex Viruses

Volumn , Issue , 2005, Pages 55-97

  Nahmias, André J ^a   Lee, Francis K ^a   Beckman Nahmias, Susanne ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961199476     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (170)

1. Du Castel P. Herpès. Pratique Dermatologique (Masson, Paris) 1901; 2: 814-815.
2. Nahmias A, Roizman B. Infection with herpes simplex viruses 1 and 2 (medical progress article). N Engl J Med 1973; 289:667-674, 719-725, 781-789.
3. Nahmias A, Josey WE. Epidemiology of herpes simplex viruses 1 and 2. In: Evans A, ed. Viral Infections of Humans. 1st ed. New York: Plenum Press, 1976:253-271.
4. Stanberry LR, Jorgensen DM, Nahmias AJ. Epidemiology of herpes simplex viruses 1 and 2. In: Evans A, Kaslow RA, eds. Viral Infections of Humans. 4th ed. New York: Plenum Press, 1997:419-454.
5. Nahmias A. The evolution (evovirology) of herpesviruses. In: Kurstak E, Maramorosch K, eds. Viruses, Evolution and Cancer. New York: Academic Press, 1974:605-622.
6. Nahmias AJ, Ballard R, Danielsson D. The evolution of sexually-transmitted and -transmissible infections in humans and animals. MSSVD/SSGM Joint Meeting of UK and Scandinavian Sexually Transmitted Infection Societies, Oslo, Norway, May 2002. MS in preparation.
7. Umene K, Sakaoka H. Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch Virol 1999; 144:637-656.
8. Frank SA. Immunology and Evolution of Infectious Diseases. Princeton, 2002.
9. Diamond J. Guns, Germs, and Steel-the Fates of Human Societies. New York, New York: W. W. Norton & Company, 1999.
10. Robinson LG, Black FL, Lee FK, Sousa AO, Owens M, Danielsson D, Nahmias AJ, Gold BD. Helicobacter pylori and indigenous peoples of South America. J Infect Dis 2002; 186:1131-1137.
11. Robinson LG, Black FL, Lee FK, Sousa AO, Danielsson D, Nahmias AJ. Sero-anthropological patterns of herpes simplex viruses 1 and 2 in American Amazon tribes. Submitted for publication.
12. Becker TM, Magder L, Harrison HR, Stewart JA, Humphrey DD, Hauler J, Nahmias AJ. The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidem 1988; 127:1071-1078.
13. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Inf Dis 1990; S69:19-36.
14. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186(suppl 1): S3-S28.
15. Smith IW, Peutherer JF, MacCallum FO. The incidence of Herpesvirus hominis antibody in the population. J Hyg (Lond) 1967; 65(3):395-408.
16. Nahmias A, Josey W, Naib Z, Luce C, Duffey C. Antibodies to herpes simplex virus types 1 and 2 in humans. I. Patients with genital herpetic infections. Am J Epidemiol 1970; 91:547-552.
17. Wentworth BB, Alexander ER. Seroepidemiology of infections due to members of the herpesvirus group. Am J Epidemiol 1971; 94(5):496-507.
18. Rawls WE, Campione-Piccardo J. Serological tests for herpes simplex. In: Nahmias AJ, Dowdle WR, Schinazi R, eds. The Human Herpesviruses. North Holland, New York: Elsevier, 1981:137-152.
19. Morris MC, Edmunds WJ, Hesketh LM, Vyse AJ, Miller E, Morgan-Capner P, Brown DW. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol 2002; 67(4):522-527.
20. Taylor T. The Prehistory of Sex-4 Million Years of Human Sexual Culture. New York: Bantam, 1996.
21. Allen GP, Bryans JT. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol 1986; 2:78-144.
22. Eberle R, Hilliard J. The simian herpesviruses. Infect Agents Dis 1995; 2: 55-70.
23. De Waal F, Lanting F. Bonobo-the Forgotten Ape. Berkeley, California: University of California Press, 1997.
24. McClure HM, Swenson RB, Kalter SS, Lester TL. Natural genital herpesvirus hominis infection in chimpanzees (Pan troglodytes and Pan paniscus). Lab Anim Sci 1980; 5:895-901.
25. Nahmias AJ, Lee F. Unpublished results.
26. Lee F, Coleman RM, Pereira L, Bailey P, Tatsuno M, Nahmias A. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 1985; 4:641-644.
27. Zihlman AL, Cronin JE, Cramer DL, Sarich VM. Pygmy chimpanzee as a possible prototype for the common ancestor of humans, chimpanzees and gorillas. Nature 1978; 275(5682):744-746.
28. Nahmias A, Dowdle W. Antigenic and biologic differences in herpes simplex viruses. Prog Med Virol 1968; 10:110-159.
29. Roizman B, Whitley RJ. The nine ages of herpes simplex virus. Herpes 2001; 8(1):23-27.
30. Naib ZM, Nahmias AJ, Josey WE. Cytology and histopathology of cervical herpes simplex. Cancer 1966; 19:1026-1030.
31. Nahmias A, Dowdle W, Naib Z, Highsmith A, Harwell R, Josey W. Relation of pock size on chorioallantoic membrane to antigenic type of herpes simplex virus. Proc Soc Exp Biol Med 1968; 127:1022-1028.
32. Juretic M. Natural history of herpetic infection. Helv Paediatr Acta 1966; 21(4):356-368.
33. Burnet FM, Lush D. Studies in experimental herpes infection in mice. J Pathol Bact 1939; 49:241-259.
34. Burnet FM, Williams SW. Herpes simplex-new point of view. Med J Aust 1939; 1:637-640.
35. Schneweis KE. Serologische Untersuchungen zur Typendifferenzierung des Herpesvirus hominis. Z Immunitaetsforsch 1962; 124:24-48.
36. Dowdle W, Nahmias A, Harwell R, Pauls F. Association of antigenic type of Herpes simplex viruses with site of viral recovery. J Immunol 1967; 99:974-980.
37. Buchman TG, Simpson T, Nosal C, Roizman B, Nahmias AJ. The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann NY Acad Sci 1980; 354:279-290.
38. Sakaoka H, Kurita K, Iida Y, Takada S, Umene K, Kim YT, Ren CS, Nahmias AJ. Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol 1994; 75:513-527.
39. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 1990; 162:306-312.
40. Gibson JJ, Lee FK, Nahmias AJ. Unpublished result.
41. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, Vandepapeliere P, Dubin G, Glaxo-Smith Kline Herpes Vaccine Efficacy Study Group. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347(21):1652-1661.
42. Schneweis KE, Nahmias AJ. Antigens of herpes simplex virus types 1 and 2- immunodiffusion and inhibition passive hemagglutination studies. Z Immunitaetsforsch 1971; 141:287-471.
43. Lee FK, Pereira L, Griffin C, Reid E, Nahmias A. A novel glycoprotein (gG-1) for detection of herpes simplex virus type 1 specific antibodies. J Virol Meth 1986; 14:111-118.
44. Nahmias AJ, Lee FK, Pereira L, Reid E, Wickliffe C. Monoclonal antibody immunoaffinity purified glycoproteins for the detection of herpes simplex virus type 1 and type 2 specific antibodies in serum. In: Roizman B, Lopez C, eds. Immunobiology of Herpesviruses. New York: Raven Press Inc, 1986: 201-210.
45. Johnson RE, Nahmias AJ, Magdner LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiological survey of the prevalence of herpes simplex type 2 in the United States. N Engl J Med 1989; 321:7-12.
46. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, St. Louis ME. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337(16):1105-1111.
47. Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, St. Louis ME. An estimate of the incidence of herpes simplex type 2 infection in the United States. Am J Epidemiol 2001; 153:912-919.
48. Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, Markowitz LE. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002; 185: 1019-1024.
49. Xu F, Sternberg M, Kottiri B, McQuillan GM, Lee F, Nahmias AJ, Markowitz L. National trends in herpes simplex 2 infection in the United States. MS Submitted for publication.
50. Schillinger J, Xu F, Armstrong GL, Sternberg M, Lee F, Nahmias AJ, McQuillan GM, St. Louis M, Markowitz L. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis 2004; 31:753-760.
51. Becker TM, Lee F, Daling JR, Nahmias AJ. Seroprevalence of and risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern Hispanic and non-Hispanic white women. Sex Transm Dis 1996; 23(2):138-144.
52. Austin H, Macaluso M, Nahmias A, Lee F, Kelaghan J, Fleenor M, Hook E II. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted diseases clinic. Sex Trans Dis 1999; 26:329-334.
53. Hashido M, Lee FK, Nahmias AJ, Tsugami H, Isomura S, Nagata Y, Sonoda S, Kawana T. Anepidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 1998; 120(2):179-186.
54. Clumeck N, Hermans P, DeWit S, Lee F, Van de Perre P, Nahmias A. Herpes Type II (HSV-2): a Possible Co-factor of the HIV Infection Among Central African Heterosexual Patients. New York: ICAAC, 1987.
55. Holmberg SD, Gerber AR, Stewart JA, Lee FK, O’Malley PM, Nahmias AJ. Herpesviruses as co-factors in AIDS. Lancet 1988; 2:746-767.
56. Holmberg SD, Stewart J, Gerber R, Byers R, Lee F, O’Malley P, Nahmias A. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259:1048-1050.
57. Keet IP, Lee FK, Griensven GJ, Lange JM, Nahmias AJ, Coutinho RA. Herpes Simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-I acquisition. Genitourin Med 1990; 66:330-333.
58. Hook E, Cannon R, Nahmias A, Lee F, Campbell C, Glasser D, Quinn T. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992; 165:251-255.
59. Boulos R, Ruff AJ, Nahmias A, Holt E, Harrison L, Magder L, Wiktor SZ, Quinn TC, Margolis H, Halsey NA. Herpes simplex type 2 infection, syphilis and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type 1 infections. J Infect Dis 1992; 166:418-420.
60. Perez G, Skurnick JH, Denny TN, Stephens R, Kennedy CA, Regivick N, Nahmias A, Lee FK, Lo SC, Wang RY, Weiss SH, Louria DB. Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. Int J Infect Dis 1998; 3(1):5-11.
61. Ashley RL, Militonio J, Lee FK, Nahmias AJ, Corey L. Comparison of Western blot and IgG-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26:662-667.
62. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002; 9(2):38-45.
63. Benedetti JK, Zeh J, Selke S, Corey L. Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus. Am J Med 1995; 98(3):237-242.
64. Nahmias A, Dowdle W, Naib Z, Josey W, Luce C. Genital infections with herpes simplex virus types 1 and 2 in children. Pediatrics 1968; 42:659-666.
65. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337(8):509-515.
66. Nahmias AJ. The continuing challenges of neonatal herpes simplex virus (HSV) infection. Herpes. Neonatal HSV infection Part I: Continuing challenges Herpes 2004; 11(2):33-37.
67. Hitti J, Watts DH, Burchett SK, Schacker T, Selke S, Brown ZA, Corey L. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997; 177(2):450-454.
68. Cruz D, Bulterys M, Wiener J, Schmid S, Dollard S, Carter R, Nesheim S, Lee F, Abrams E, Palumbo P, Nahmias AJ. Seroprevalence and risk factors of herpes simplex virus type 1 and 2 infections among HIV infected women in the United States, 1986-98. MS in preparation.
69. Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis 2003; 187(4):542-549.
70. Barton S, Celum C, Schacker TW. The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIVepidemic. Herpes 2005; 12(1):15-22.
71. Coyle PV, O’Neill HJ, Wyatt DE, McCaughey C, Quah S, McBride MO. Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland. J Clin Virol 2003; 27(1):22-29.
72. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000; 79(8):693-696.
73. Nahmias A, Dannenbarger J, Wickliffe C, Muther J. Clinical aspects of herpes simplex virus infections. In: Nahmias A, Dowdle A, Schinazi R, eds. The Human Herpesviruses-an Interdisciplinary Perspective. North Holland, New York: Elsevier, 1981:3-9.
74. Lakeman AD, Nahmias A, Whitley R. Analysis of DNA from recurrent genital isolates by restriction endonuclease digestion. Sex Transm Dis 1986; 13:61-66.
75. Whitley R, Lakeman F, Nahmias A, Roizman B. DNA restriction enzyme analysis of herpes simplex virus isolates from patients with encephalitis. N Engl J Med 1982; 307:1060-1062.
76. Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L. Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J Infect Dis 1998; 177(4):1069-1072.
77. Lowhagen GB, Tunback P, Bergstrom T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Dermatol Venereol 2002; 82(2):118-120.
78. Kuzushima K, Kimura H, Kino Y, Kido S, Hanada N, Shibata M, Morishima T. Clinicalmanifestations of primary herpes simplex virus type 1 infection in a closed community. Pediatrics 1991; 87(2):152-158.
79. Bodurtha J, Adler SP, Nance WE. Seroepidemiology of cytomegalovirus and herpes simplex virus in twins and their families. Am J Epidemiol 1988; 128(2):268-276.
80. Tunback P, Bergstrom T, Andersson AS, Nordin P, Krantz I, Lowhagen GB. Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand J Infect Dis 2003; 35(8):498-502.
81. Kawana T. Sexually transmitted diseases of alpha herpes virus in women. Nippon Rinsho 2000; 58(4):883-889.
82. Spicher VM, Bouvier P, Schlegel-Haueter SE, Morabia A, Siegrist CA. Epidemiology of herpes simplex virus in children by detection of specific antibodies in saliva. Pediatr Infect Dis J 2001; 20(3):265-272.
83. Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76(3):183-187.
84. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181(4):1454-1457.
85. Ribes JA, Steele AD, Seabolt JP, Baker DJ. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol 2001; 39(9):3321-3325.
86. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30(10):797-800.
87. Sexual Health Update. A Quarterly Publication of The Medical Institute. Austin, Texas, Spring 2003.
88. Marrazzo JM, Stine K, Wald A. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians. Sex Transm Dis 2003; 30(12):890-895.
89. Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993; 69(5):381-383.
90. Tayal SC, Pattman RS. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. Int J STD AIDS 1994; 5(5):359-361.
91. Lowhagen GB, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 2000; 76(3):179-182.
92. Lippelt L, Braun RW, Kuhn JE. Genital herpes simplex virus type 1 infection: new fields for an old acquaintance? Intervirology 2002; 45(1):2-5.
93. Cowan FM, Copas A, Johnson AM, Ashley R, Corey L, Mindel A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex Transm Infect 2002; 78(5):346-348.
94. Scoular A, Norrie J, Gillespie G, Mir N, Carman WF. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002; 324(7350):1366-1367.
95. Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Dis 2003; 30(10): 794-796.
96. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121(11):847-854.
97. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289(2):203-209.
98. Gaytant MA, Steegers EA, van Laere M, Semmekrot BA, Groen J, Weel JF, van der Meijden WI, Boer K, Galama JM. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands. Sex Transm Dis 2002; 29(11):710-714.
99. Martin L. Orofacial herpes and other localizations (genital herpes and neonatal herpes excluded). Ann Dermatol Venereol 2002; 129(4 Pt 2):494-506.
100. Koskiniemi M, Rantalaiho T, Piiparinen H, von Bonsdorff CH, Farkkila M, Jarvinen A, Kinnunen E, Koskiniemi S, Mannonen L, Muttilainen M, et al., Study Group. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol 2001; 7(5):400-408.
101. Kennedy PG, Chaudhuri A. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 2002; 73(3):237-238.
102. Gammon JA, Nahmias AJ. Herpes simplex ocular infections in the newborn. In: Darrell RW, ed. Viral Diseases of the Eye. Philadelphia, PA: Lea and Febiger Publishers, 1985:46-58.
103. Kaufman HE. Can we prevent recurrences of herpes infections without antiviral drugs? The Weisenfeld Lecture. Invest Ophthalmol Vis Sci 2002; 43(5):1325-1329.
104. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20(1):1-13.
105. Slavin HB, Gavett E. Antigenic dissimilarity between strains of herpes simplex virus. Proc Soc Exp Biol New York 1946; 63:345-347.
106. Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998; 391:594-597.
107. Malkin J-E. Epidemiology of genital herpes simplex virus infection in developed host countries. Herpes 2004; 11(Supp):2A-23A.
108. Weiss H. Epidemiology of herpes type 2 infection in the developing world. Herpes 2004; 11(Supp):24A-35A.
109. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996; 174(3):470-475.
110. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997; 99(5):1092-1097.
111. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333(12):770-775.
112. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116(3):197-202.
113. Cone RW, Hobson AC, Brown Z, Ashley R, Berry S, Winter C, Corey L. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 1994; 272(10):792-796.
114. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185(1):45-52.
115. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM, Jr., Paavonen J, Morrow RA, Beutner KR, et al., Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350(1):11-20.
116. Nahmias AJ. Neonatal infection Part II: Obstetric considerations. Herpes 2004; 11(2):41-44.
117. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, et al., National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108(2):223-229.
118. Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, Tyring S, Douglas JM, Jr., Corey L. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285 (24):3100-3106.
119. Forsgren M. Genital herpes simplex virus infection and incidence of neonatal disease in Sweden. Scand J Infect Dis Suppl 1990; 69:37-41.
120. Malkin JE, Morand P, Malvy D, Ly TD, Chanzy B, de Labareyre C, El Hasnaoui A, Hercberg S. Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect 2002; 78(3):201-203.
121. Nahmias AJ, Alford CA, Korones SB. Infection of the newborn with Herpesvirus hominis. Adv Pediatr 1970; 17:185-226.
122. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, et al., National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108(2):230-238.
123. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37(3):319-325.
124. Hashido M, Lee FK, Nahmias A, Inouye S, Miyata K, Nagata Y, Sonoda S, Kawana T. Herpes simplex virus type 1 and 2, chlamydia, syphilis, and toxoplasma infections in pregnant Japanese women with human T-lymphotropic virus type 1 infection. J AIDS Hum Retrovir 1998; 17:95-97.
125. Stewart JA, Reef SE, Pellett PE, Corey L, Whitley RJ. Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(suppl 1):S114-S120.
126. Roberts CM. Genital herpes in young adults-changing sexual behaviours, epidemiology and management. Herpes 2005; 12(1):10-149.
127. Mostad SB, Kreiss JK, Ryncarz AJ, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo JJ, Corey L. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 2000; 181(1):58-63.
128. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996; 23(5):429-440.
129. Chen CY, Ballard RC, Beck-Sague CM, Dangor Y, Radebe F, Schmid S, Weiss JB, Tshabalala V, Fehler G, Htun Y, Morse SA. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000; 27(1):21-29.
130. Bruisten SM, Cairo I, Fennema H, Pijl A, Buimer M, Peerbooms PG, Van Dyck E, Meijer A, Ossewaarde JM, van Doornum GJ. Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol 2001; 39(2):601-605.
131. Kraus SJ. Evaluation and management of acute genital ulcers in sexually active patients. Urol Clin North Am 1984; 11(1):155-162.
132. Sanchez J, Volquez C, Totten PA, Campos PE, Ryan C, Catlin M, Hasbun J, Rosado De Quinones M, Sanchez C, De Lister MB, Weiss JB, Ashley R, Holmes KK. The etiology and management of genital ulcers in the Dominican Republic and Peru. Sex Transm Dis 2002; 29(10):559-567.
133. Gadkari DA, Quinn TC, Gangakhedkar RR, Mehendale SM, Divekar AD, Risbud AR, Chan-Tack K, Shepherd M, Gaydos C, Bollinger RC. HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(3):277-281.
134. Mwansasu A, Mwakagile D, Haarr L, Langeland N. Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania. J Clin Virol 2002; 24(3):183-192.
135. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280(1):61-66.
136. Ballard R, Htun Y, Dangor Y. HIV and genital ulcer disease: determinants of HIV shedding from lesions and consequences of therapy. In: Program and abstracts of the 13th Annual Meeting of the International Society for Sexually Transmitted Disease Research, Denver, Colorado, 1999:51.
137. Vlach J, Pitha PM. Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus. J Virol 1993; 67(7):4427-4431.
138. Boerma JT, Gregson S, Nyamukapa C, Urassa M. Understanding the uneven spread of HIV within Africa: comparative study of biologic, behavioral, and contextual factors in rural populations in Tanzania and Zimbabwe. Sex Transm Dis 2003; 30(10):779-787.
139. del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002; 16(3):451-462.
140. Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30(2):261-267.
141. Renzi C, Douglas JM Jr, Foster M, Critchlow CW, Ashley-Morrow R, Buchbinder SP, Koblin BA, McKirnan DJ, Mayer KH, Celum CL. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis 2003; 187(1):19-25.
142. Mbopi-Keou FX, Robinson NJ, Mayaud P, Belec L, Brown DW. Herpes simplex virus type 2 and heterosexual spread of human immunodeficiency virus infection in developing countries: hypotheses and research priorities. Clin Microbiol Infect 2003; 9(3):161-171.
143. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, Divekar AD, Gangakhedkar RR, Ghate MV, Bollinger RC, Mehendale SM. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187(10):1513-1521.
144. Stover CT, Smith DK, Schmid DS, Pellett PE, Stewart JA, Klein RS, Mayer K, Vlahov D, Schuman P, Cannon MJ, HIV Epidemiology Research Study Group. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis 2003; 187(9):1388-1396.
145. Risbud A, Chan-Tack K, Gadkari D, Gangakhedkar RR, Shepherd ME, Bollinger R, Mehendale S, Gaydos C, Divekar A, Rompalo A, Quinn TC. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis 1999; 26(1):55-62.
146. Lai W, Chen CY, Morse SA, Htun Y, Fehler HG, Liu H, Ballard RC. Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sex Transm Infect 2003; 79(3):202-207.
147. Weiss HA, Buve A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, Musonda R, Zekeng L, Morison L, Carael M, Laga M, Hayes RJ, Study Group on Heterogeneity of HIV Epidemics in African Cities. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001; 15(suppl 4):S97-S108.
148. Sartre JP. Why write? In: What Is Literature and Other Essays? Cambridge, MA: Harvard University Press, 1988.
149. WHO/UNAIDS/LSHTM Workshop. Herpes Simplex Virus Type 2. Programmatic and Research Priorities in Developing Countries. London: WHO, Feb 14-16, 2001.
150. Bernstein DI. Potential for immunotherapy in the treatment of herpesvirus infections. Herpes 2001; 8(1):8-11.
151. Au E, Sacks SL. Antivirals in the prevention of genital herpes. Herpes 2002; 9(3):74-77.
152. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD Jr. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87(1):69-73.
153. Naesens L, De Clercq E. Recent developments in herpesvirus therapy. Herpes 2001; 8(1):12-16.
154. Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003; 26(1):29-37.
155. Reyes M, Shaik NS, Graber JM, Nisenbaum R, Wetherall NT, Fukuda K, Reeves WC. Task Force on Herpes Simplex Virus Resistance. Acyclovirresistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003; 163(1): 76-80.
156. Kleymann G. New antiviral drugs that target Herpesvirus helicase primase enzymes. Herpes 2003; 10(2):46-52.
157. Whitley RJ, Roizman B. Herpes simplex viruses: is a vaccine tenable? J Clin Invest 2002; 110(2):145-151.
158. Casper C, Wald A. Condom use and the prevention of genital herpes acquisition. Herpes 2002; 9(1):10-14.
159. Scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. NIAID, NIH Workshop Summary, Herndon, Virginia, June 12-13, 2000.
160. Sex, Condoms & STDs: What We Now Know. Austin, Texas: The Medical Institute for Sexual Health, 2002.
161. Watts DH, Brown ZA, Money D, Selke S, Huang ML, Sacks SL, Corey L. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003; 188(3):836-843.
162. Zeitlin L, Whaley KJ. Microbicides for preventing transmission of genital herpes. Herpes 2002; 9(1):4-9.
163. Fisman DN, Lipsitch M, Hook EW, III, Goldie SJ. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis 2002; 29(10):608-622.
164. Stone KM, Brooks CA, Guinan ME, Alexander ER. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis 1989; 16(3):152-156.
165. Koskiniemi M, Happonen JM, Jarvenpaa AL, Pettay O, Vaheri A. Neonatal herpes simplex virus infection: a report of 43 patients. Pediatr Infect Dis J 1989; 8(1):30-35.
166. Mindel A, Taylor J. Debate: the argument against. Should every STD clinic patient be considered for type-specific serological screening for HSV? Herpes 2002; 9(2):35-37.
167. Nahmias AJ. Routine use of HSV-1 and HSV-2 antibody testing. Herpes 2002; 9(3):83.
168. Arvin AM. Debate: the argument against. Should all pregnant women be offered type-specific serological screening for HSV infection? Herpes 2002; 9(2):48-50
169. Becker TM. Herpes gladiatorum: a growing problem in sports medicine. Cutis 1992; 50(2):150-152.
170. Anderson BJ. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers. Clin J Sport Med 1999; 9(2):86-90.